Omapren (Omeprazole)

Omeprazole, the active ingredient in Omapren, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omapren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omapren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omapren is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients requiring long‑term NSAID therapy.

Adverse reactions to omeprazole are reported across a spectrum of frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea or abdominal discomfort: transient. - Flatulence: occasional. - Constipation: mild. - Dry mouth: occasional.

Serious or Rare Side Effects: - Clostridioides difficile infection: may occur with prolonged use. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Hypomagnesemia: low serum magnesium with long‑term therapy. - Vitamin B12 deficiency: possible with extended treatment. - Bone fractures: increased risk with chronic high‑dose use. - Liver enzyme elevations: rare hepatic involvement.

When prescribing Omapren, consider the following safety measures: - Assess renal and hepatic function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term users: watch for nutrient deficiencies and bone health. - Use in pregnancy and lactation only if clearly needed: weigh benefits against potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring clinical awareness.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, consider alternative therapy. - Atazanavir and other protease inhibitors: decreased absorption, avoid co‑administration. - Methotrexate (high‑dose): increased serum levels, monitor closely.

Moderate Interiactions (M...